Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8120520rdf:typepubmed:Citationlld:pubmed
pubmed-article:8120520lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:8120520lifeskim:mentionsumls-concept:C0021670lld:lifeskim
pubmed-article:8120520lifeskim:mentionsumls-concept:C0028833lld:lifeskim
pubmed-article:8120520lifeskim:mentionsumls-concept:C0311400lld:lifeskim
pubmed-article:8120520lifeskim:mentionsumls-concept:C0544452lld:lifeskim
pubmed-article:8120520pubmed:issue3lld:pubmed
pubmed-article:8120520pubmed:dateCreated1994-4-6lld:pubmed
pubmed-article:8120520pubmed:abstractTextThe efficacy of octreotide was studied in a group of patients with biochemical evidence of insulinoma.lld:pubmed
pubmed-article:8120520pubmed:languageenglld:pubmed
pubmed-article:8120520pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8120520pubmed:citationSubsetIMlld:pubmed
pubmed-article:8120520pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8120520pubmed:statusMEDLINElld:pubmed
pubmed-article:8120520pubmed:monthMarlld:pubmed
pubmed-article:8120520pubmed:issn0954-6820lld:pubmed
pubmed-article:8120520pubmed:authorpubmed-author:HagenCClld:pubmed
pubmed-article:8120520pubmed:authorpubmed-author:NielsenHHlld:pubmed
pubmed-article:8120520pubmed:authorpubmed-author:von EybenF...lld:pubmed
pubmed-article:8120520pubmed:authorpubmed-author:GjessingH JHJlld:pubmed
pubmed-article:8120520pubmed:authorpubmed-author:GrodumEElld:pubmed
pubmed-article:8120520pubmed:issnTypePrintlld:pubmed
pubmed-article:8120520pubmed:volume235lld:pubmed
pubmed-article:8120520pubmed:ownerNLMlld:pubmed
pubmed-article:8120520pubmed:authorsCompleteYlld:pubmed
pubmed-article:8120520pubmed:pagination245-8lld:pubmed
pubmed-article:8120520pubmed:dateRevised2010-3-24lld:pubmed
pubmed-article:8120520pubmed:meshHeadingpubmed-meshheading:8120520-...lld:pubmed
pubmed-article:8120520pubmed:meshHeadingpubmed-meshheading:8120520-...lld:pubmed
pubmed-article:8120520pubmed:meshHeadingpubmed-meshheading:8120520-...lld:pubmed
pubmed-article:8120520pubmed:meshHeadingpubmed-meshheading:8120520-...lld:pubmed
pubmed-article:8120520pubmed:meshHeadingpubmed-meshheading:8120520-...lld:pubmed
pubmed-article:8120520pubmed:meshHeadingpubmed-meshheading:8120520-...lld:pubmed
pubmed-article:8120520pubmed:meshHeadingpubmed-meshheading:8120520-...lld:pubmed
pubmed-article:8120520pubmed:meshHeadingpubmed-meshheading:8120520-...lld:pubmed
pubmed-article:8120520pubmed:meshHeadingpubmed-meshheading:8120520-...lld:pubmed
pubmed-article:8120520pubmed:meshHeadingpubmed-meshheading:8120520-...lld:pubmed
pubmed-article:8120520pubmed:meshHeadingpubmed-meshheading:8120520-...lld:pubmed
pubmed-article:8120520pubmed:meshHeadingpubmed-meshheading:8120520-...lld:pubmed
pubmed-article:8120520pubmed:year1994lld:pubmed
pubmed-article:8120520pubmed:articleTitleMetabolic remission with octreotide in patients with insulinoma.lld:pubmed
pubmed-article:8120520pubmed:affiliationDepartment of Internal Medicine and Endocrinology, Odense University Hospital, Denmark.lld:pubmed
pubmed-article:8120520pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8120520pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:8120520pubmed:publicationTypeClinical Trial, Phase IIlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8120520lld:pubmed